Related Experiment Video
Updated: Jul 7, 2026
Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
Biology of somatostatin in breast cancer
Heather L Watt1, G Kharmate, Ujendra Kumar
1Department of Medicine, Royal Victoria Hospital, McGill University, Canada.
Abstract:
The biological effects of the neuropeptide somatostatin (SST) are mediated via a family of five somatostatin receptors (SSTRs) belonging to a family of G-protein-coupled receptors (GPCRs). SSTR regulate the secretion of hormones, growth factors, neurotransmission and cell growth in receptor-specific manner. In addition, SST plays an inhibitory role in several mammary cancer models. These effects are mediated both indirectly through inhibition of hormones and growth factors which promote tumor growth as well as directly via SSTRs present on tumor cells to inhibit mitogenic signaling of growth factor receptor kinases leading to growth arrest and induction of apoptosis. Here, we present an overview on the role of SST and its analogs in breast cancer.
Insights
Somatostatin (SST) and its receptors (SSTRs) inhibit breast cancer growth. These neuropeptides offer potential therapeutic strategies by blocking tumor cell proliferation and promoting apoptosis.
Area of Science:
- Endocrinology
- Oncology
- Neuroscience
Background:
- Somatostatin (SST) is a neuropeptide with diverse biological functions.
- Its effects are mediated through five somatostatin receptors (SSTRs), a class of G-protein-coupled receptors (GPCRs).
- SST has demonstrated inhibitory effects in various mammary cancer models.
Purpose of the Study:
- To provide an overview of somatostatin's role in breast cancer.
- To discuss the mechanisms by which SST influences mammary tumors.
- To explore the potential of SST and its analogs as therapeutic agents in breast cancer.
Main Methods:
- Review of existing literature on somatostatin and breast cancer.
- Analysis of indirect mechanisms involving hormone and growth factor regulation.
- Examination of direct mechanisms involving SSTR signaling on tumor cells.
Main Results:
- SST inhibits tumor growth indirectly by suppressing hormones and growth factors.
- SST directly acts on tumor cells via SSTRs to inhibit mitogenic signaling.
- These direct effects lead to growth arrest and apoptosis induction in cancer cells.
Conclusions:
- Somatostatin plays a significant inhibitory role in breast cancer progression.
- Targeting SSTRs offers a promising therapeutic avenue for breast cancer treatment.
- SST analogs warrant further investigation for their clinical application in managing breast cancer.
